{
    "relation": [
        [
            "",
            "FluNG Group",
            "Fluarix Group"
        ],
        [
            "Description",
            "subjects received 2 doses (1 dose per season) of FluNG vaccine during the Northern Hemisphere (NH) vaccination periods. One dose at Day 0 of the Year 1 and one dose at Day 0 of the Year 2 (= Day 365 Year 1).",
            "subjects received 2 doses (1 dose per season) of Fluarix\u2122 vaccine during the Northern Hemisphere (NH) vaccination periods. One dose at Day 0 of the Year 1 and one dose at Day 0 of the Year 2 (= Day 365 Year 1)."
        ]
    ],
    "pageTitle": "Trial to Evaluate the Efficacy of GSK Biologicals' Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older - Study Results - ClinicalTrials.gov",
    "title": "",
    "url": "https://clinicaltrials.gov/ct2/show/results/NCT00753272?sect=Xlu015&view=results",
    "hasHeader": true,
    "headerPosition": "MIXED",
    "tableType": "RELATION",
    "tableNum": 25,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042990177.43/warc/CC-MAIN-20150728002310-00189-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 857212527,
    "recordOffset": 857193853,
    "tableOrientation": "HORIZONTAL",
    "textBeforeTable": "Reporting Groups For lot-to-lot consistency analyses after Dose 1 at Day 0 of the Year 1, FluNG Group was divided in 3 sub-groups: FluNG Lot 1 Group, FluNG Lot 2 Group and FluNG Lot 3 Group: subjects received 1 dose of FluNG vaccine Lot 1, 2 or 3 at Day 0 of the Year 1. They all received Dose 2 at Day 0 of the Year 2, again from 3 different lots. Significant events and approaches for the overall study following participant enrollment, but prior to group assignment Pre-Assignment Details Subjects were vaccinated during the pre-influenza season at Day 0, were contacted by phone during the surveillance period from mid November to the end of the influenza season (April-May) and were contacted by phone at Days 270 and 365 for the Year 1 influenza season 2008/2009 and the Year 2 influenza season 2009/2010. Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations Recruitment Details \u00a0 Hide Participant Flow \u00a0 Participant",
    "textAfterTable": "Participant Flow: \u00a0 Overall Study \u00a0 \u00a0 FluNG Group \u00a0 \u00a0 Fluarix Group \u00a0 STARTED \u00a0 \u00a0 21893 \u00a0 \u00a0 21802 \u00a0 COMPLETED \u00a0 \u00a0 16911 \u00a0 \u00a0 16895 \u00a0 NOT COMPLETED \u00a0 \u00a0 4982 \u00a0 \u00a0 4907 \u00a0 Adverse Event \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 878 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 869 \u00a0 Protocol Violation \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 28 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 46 \u00a0 Withdrawal by Subject \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 2481 \u00a0 \u00a0",
    "hasKeyColumn": true,
    "keyColumnIndex": 0,
    "headerRowIndex": 0
}